Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,525.20
+1.40 (0.09%)
At close: Nov 27, 2025
Cipla Market Cap
Cipla has a market cap or net worth of 1.23 trillion as of November 26, 2025. Its market cap has decreased by -4.30% in one year.
Market Cap
1.23T
Enterprise Value
1.13T
Revenue
279.66B
Ranking
n/a
PE Ratio
22.66
Stock Price
1,525.20
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.23T, an increase of 81,290.70%. That is a compound annual growth rate of 25.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 1.23T | -0.32% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | 661.25B | 71.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.26T |
| Divi's Laboratories | 1.70T |
| Apollo Hospitals Enterprise | 1.05T |
| Zydus Lifesciences | 934.29B |
| Mankind Pharma | 925.36B |
| Aurobindo Pharma | 701.61B |
| Fortis Healthcare | 694.86B |
| Alkem Laboratories | 681.64B |